Stay updated on Cardiol Therapeutics Press Releases
Sign up to get notified when there's something new on the Cardiol Therapeutics Press Releases page.

Latest updates to the Cardiol Therapeutics Press Releases page
- Check6 days agoChange DetectedAdded a new press release headline about ARCHER trial data dated November 29, 2025 and updated stock prices to 0.9401 and 1.30. Removed the May 27, 2025 AGM webcast entry (May 28th webcast).SummaryDifference1%

- Check13 days agoChange DetectedStock price values in the investor sidebar updated from $1.02 and $1.44 to $0.973 and $1.38.SummaryDifference0.5%

- Check20 days agoChange DetectedAdded a new press release headline 'Cardiol Therapeutics Receives U.S. Patent Allowance Broadly Protecting its Heart Drugs to Late 2040' (Nov 13, 2025); stock price updated to $1.44. Removed the older press release about nominating Dr. Timothy Garnett to the Board of Directors (Apr 29, 2025).SummaryDifference1%

- Check27 days agoChange DetectedAdded a new press release item for November 5, 2025 about ARCHER trial results to be presented at the ESC, and updated the stock quote panel; the older MAVERIC enrollment press release was removed.SummaryDifference1%

- Check34 days agoChange DetectedStock ticker values in the header were updated from $1.19 NASDAQ:CRDL and $1.66 TSX:CRDL to $1.13 NASDAQ:CRDL and $1.54 TSX:CRDL.SummaryDifference1%

- Check42 days agoChange DetectedThe TSX:CRDL price displayed in the investor widget updated from 1.67 to 1.66.SummaryDifference0.2%

Stay in the know with updates to Cardiol Therapeutics Press Releases
Enter your email address, and we'll notify you when there's something new on the Cardiol Therapeutics Press Releases page.